Abdulla K Salahudeen

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. pmc Incidence rate, clinical correlates, and outcomes of AKI in patients admitted to a comprehensive cancer center
    Abdulla K Salahudeen
    Division of Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Clin J Am Soc Nephrol 8:347-54. 2013
  2. ncbi The frequency, cost, and clinical outcomes of hypernatremia in patients hospitalized to a comprehensive cancer center
    Abdulla K Salahudeen
    Division of Internal Medicine, UT MD Anderson Cancer Center, Houston, TX, USA
    Support Care Cancer 21:1871-8. 2013
  3. doi Onconephrology: the latest frontier in the war against kidney disease
    Abdulla K Salahudeen
    Nephrology Section, Department of General Internal Medicine, University of Texas M D Anderson Cancer Center, 1400 Pressler Street, Unit 1465, FCT13 5050, Houston, TX, USA
    J Am Soc Nephrol 24:26-30. 2013
  4. pmc Sustained low efficiency dialysis in the continuous mode (C-SLED): dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients
    Abdulla K Salahudeen
    Nephrology Section, Department of General Internal Medicine AT and EC, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Clin J Am Soc Nephrol 4:1338-46. 2009
  5. pmc Fenoldopam preconditioning: role of heme oxygenase-1 in protecting human tubular cells and rodent kidneys against cold-hypoxic injury
    Abdulla K Salahudeen
    Nephrology Section, General Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Transplantation 91:176-82. 2011
  6. doi Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes
    Simit M Doshi
    Division of Internal Medicine, University of Texas M D Anderson Cancer Center, Houston, 77030, USA
    Am J Kidney Dis 59:222-8. 2012
  7. ncbi Costs and outcomes of acute kidney injury in critically ill patients with cancer
    Amit Lahoti
    Department of General Internal Medicine, Section of Nephrology, The University of Texas M D Anderson Cancer Center, PO Box 301402, FCT 13 6068, Houston, TX, 77230 1402, USA
    J Support Oncol 9:149-55. 2011
  8. doi Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury
    Abdulla K Salahudeen
    Department of Medicine, University of Mississippi Medical Center, Jackson, MI, USA
    Am J Physiol Renal Physiol 294:F1354-65. 2008
  9. ncbi Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome
    Amit Lahoti
    Department of General Internal Medicine, Ambulatory Treatment and Emergency Center, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Cancer 116:4063-8. 2010
  10. doi Urinary tubular protein-based biomarkers in the rodent model of cisplatin nephrotoxicity: a comparative analysis of serum creatinine, renal histology, and urinary KIM-1, NGAL, and NAG in the initiation, maintenance, and recovery phases of acute kidney inj
    Vikash Sinha
    Nephrology Section, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    J Investig Med 61:564-8. 2013

Detail Information

Publications12

  1. pmc Incidence rate, clinical correlates, and outcomes of AKI in patients admitted to a comprehensive cancer center
    Abdulla K Salahudeen
    Division of Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Clin J Am Soc Nephrol 8:347-54. 2013
    ..Incidence of AKI in hospitalized patients with cancer is increasing, but reports are scant. The objective of this study was to determine incidence rate, clinical correlates, and outcomes of AKI in patients admitted to a cancer center...
  2. ncbi The frequency, cost, and clinical outcomes of hypernatremia in patients hospitalized to a comprehensive cancer center
    Abdulla K Salahudeen
    Division of Internal Medicine, UT MD Anderson Cancer Center, Houston, TX, USA
    Support Care Cancer 21:1871-8. 2013
    ..To study the frequency of hypernatremia in hospitalized cancer patients and its impact on clinical outcomes and healthcare cost...
  3. doi Onconephrology: the latest frontier in the war against kidney disease
    Abdulla K Salahudeen
    Nephrology Section, Department of General Internal Medicine, University of Texas M D Anderson Cancer Center, 1400 Pressler Street, Unit 1465, FCT13 5050, Houston, TX, USA
    J Am Soc Nephrol 24:26-30. 2013
    ..This update addresses what is clinically unique about onconephrology, the objectives and functions of the newly formed forum, and the potential of onconephrology becoming a subspecialty in nephrology...
  4. pmc Sustained low efficiency dialysis in the continuous mode (C-SLED): dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients
    Abdulla K Salahudeen
    Nephrology Section, Department of General Internal Medicine AT and EC, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Clin J Am Soc Nephrol 4:1338-46. 2009
    ..C-SLED through higher clearance may improve survival, or through greater nutritional loss may worsen survival. No studies have assessed survival on C-SLED. The objective was to examine patient outcomes and survival predictors on C-SLED...
  5. pmc Fenoldopam preconditioning: role of heme oxygenase-1 in protecting human tubular cells and rodent kidneys against cold-hypoxic injury
    Abdulla K Salahudeen
    Nephrology Section, General Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Transplantation 91:176-82. 2011
    ..Studies suggest that donor preconditioning with dopaminergics may reduce cold-ischemic transplant injury, but whether heme oxygenase (HO)-1 induction is an underlying mechanism is not known...
  6. doi Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes
    Simit M Doshi
    Division of Internal Medicine, University of Texas M D Anderson Cancer Center, Houston, 77030, USA
    Am J Kidney Dis 59:222-8. 2012
    ..Hyponatremia is the most common electrolyte abnormality in clinical practice, yet little is known about its frequency in patients with cancer or its impact on their clinical outcomes...
  7. ncbi Costs and outcomes of acute kidney injury in critically ill patients with cancer
    Amit Lahoti
    Department of General Internal Medicine, Section of Nephrology, The University of Texas M D Anderson Cancer Center, PO Box 301402, FCT 13 6068, Houston, TX, 77230 1402, USA
    J Support Oncol 9:149-55. 2011
    ..The utility of the RIFLE criteria in critically ill patients with cancer is not known...
  8. doi Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury
    Abdulla K Salahudeen
    Department of Medicine, University of Mississippi Medical Center, Jackson, MI, USA
    Am J Physiol Renal Physiol 294:F1354-65. 2008
    ....
  9. ncbi Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome
    Amit Lahoti
    Department of General Internal Medicine, Ambulatory Treatment and Emergency Center, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Cancer 116:4063-8. 2010
    ..The objective of the current study was to identify the incidence, predictors, and outcome for AKI in patients with AML and HR-MDS...
  10. doi Urinary tubular protein-based biomarkers in the rodent model of cisplatin nephrotoxicity: a comparative analysis of serum creatinine, renal histology, and urinary KIM-1, NGAL, and NAG in the initiation, maintenance, and recovery phases of acute kidney inj
    Vikash Sinha
    Nephrology Section, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    J Investig Med 61:564-8. 2013
    ..Several biomarkers are becoming available for the early detection of acute kidney injury (AKI), but few have been directly compared...
  11. ncbi Tolvaptan in hospitalized cancer patients with hyponatremia: A double-blind, randomized, placebo-controlled clinical trial on efficacy and safety
    Abdulla K Salahudeen
    Nephrology Section, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
    Cancer 120:744-51. 2014
    ..The availability of V2 receptor antagonists has been a major breakthrough in the management of hyponatremia, but its efficacy and safety in treating hyponatremia in patients with cancer is not known...
  12. doi Nonerythropoietic properties of erythropoietin: implication for tissue protection
    Dhanesh B Rathod
    Nephrology Section, Department of General Internal Medicine, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    J Investig Med 59:1083-5. 2011
    ..Also provided is a brief description of potential pathways through which EPO may be mediating this effect...